Nanologica was founded in 2004 and is a nanotechnology company developing nanoporous silica particles for applications within life science. Nanologica is world leading in controlling shape, porosity and surface characteristics of silica particles. This competency is applied in two business areas – drug development and chromatography, a separation technique used in drug development and drug production. The Company’s mission is to contribute to providing better and cheaper treatments for patients worldwide through the technology platform NLAB Silica™. The Company’s share (NICA) is traded on Spotlight Stock Market.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.